FDAClass IIFebruary 18, 2026

Cetrorelix Acetate for Injection recall

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Why was Cetrorelix Acetate for Injection recalled?

Defective Delivery System: Missing or duplicated needles within the injection kit

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot Q4E0112A, Exp.: 30 Apr 2027

Product
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Recalling firm
Meitheal Pharmaceuticals, Inc
Quantity
16,477 kits
Distribution
U.S. Nationwide
Recall date
February 18, 2026
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls